Chronic parkinsonism associated with cirrhosis: a distinct subset of acquired hepatocerebral degeneration - PubMed (original) (raw)
Chronic parkinsonism associated with cirrhosis: a distinct subset of acquired hepatocerebral degeneration
Pierre R Burkhard et al. Arch Neurol. 2003 Apr.
Abstract
Context: The clinical, neuroradiological, and biological characteristics of the so-called acquired hepatocerebral degeneration have not yet been fully determined and its frequency remains largely uncertain.
Objectives: To prospectively study the prevalence of extrapyramidal symptoms in patients with moderate to severe cirrhosis of various causes, to delineate the main neurological features of the condition, and to establish correlations with neuroradiological and biological findings.
Patients and methods: During a 1-year period, all consecutive patients with cirrhosis who were potential candidates for liver transplantation were screened for extrapyramidal features. When extrapyramidal features were present, further workup included a detailed neurological examination, magnetic resonance imaging of the brain, a comprehensive battery of neuropsychological tests, extensive blood tests, and, in some cases, cerebrospinal fluid analysis.
Setting: A community-based hospital.
Results: From 51 patients screened, 11 (21.6%) exhibited moderate to severe parkinsonism sometimes associated with focal dystonia. Typical features included rapid progression over months, symmetric akinetic-rigid syndrome, postural but not resting tremor, and early postural and gait impairment. Neuropsychiatric manifestations were minimal. Some patients were responsive to levodopa therapy. In all patients, magnetic resonance imaging scans showed striking hyperintensities on T1-weighted images typically involving the substantia nigra and the globus pallidus bilaterally. Whole blood and cerebrospinal fluid manganese concentrations were severalfold above the reference range.
Conclusions: Cirrhosis-related parkinsonism may represent a unique, consistent, and common subset of acquired hepatocerebral degeneration, whose features are permanent and entirely different from acute hepatic encephalopathy episodes. This form of parkinsonism can be clearly distinguished from other forms of parkinsonism of middle to advanced age, based on a suggestive association of clinical, neuroradiological, and biological abnormalities. Our findings support the concept of the toxic effects of manganese being the major determinant of basal ganglia dysfunction leading to the predominantly extrapyramidal central nervous system manifestations of cirrhosis observed in these patients.
Similar articles
- Atypical parkinsonism in Guadeloupe: a common risk factor for two closely related phenotypes?
Lannuzel A, Höglinger GU, Verhaeghe S, Gire L, Belson S, Escobar-Khondiker M, Poullain P, Oertel WH, Hirsch EC, Dubois B, Ruberg M. Lannuzel A, et al. Brain. 2007 Mar;130(Pt 3):816-27. doi: 10.1093/brain/awl347. Epub 2007 Feb 15. Brain. 2007. PMID: 17303592 - [Chronic acquired hepatocerebral degeneration. Two case reports].
Martín Romano L, Alfredo Femminini R. Martín Romano L, et al. Neurologia. 2007 Jul-Aug;22(6):391-4. Neurologia. 2007. PMID: 17610169 Spanish. - [The onset of psychiatric disorders and Wilson's disease].
Benhamla T, Tirouche YD, Abaoub-Germain A, Theodore F. Benhamla T, et al. Encephale. 2007 Dec;33(6):924-32. doi: 10.1016/j.encep.2006.08.009. Epub 2007 Sep 5. Encephale. 2007. PMID: 18789784 French. - The diagnosis of manganese-induced parkinsonism.
Cersosimo MG, Koller WC. Cersosimo MG, et al. Neurotoxicology. 2006 May;27(3):340-6. doi: 10.1016/j.neuro.2005.10.006. Epub 2005 Dec 1. Neurotoxicology. 2006. PMID: 16325915 Review.
Cited by
- Parkinsonism in cirrhosis: pathogenesis and current therapeutic options.
Butterworth RF. Butterworth RF. Metab Brain Dis. 2013 Jun;28(2):261-7. doi: 10.1007/s11011-012-9341-7. Epub 2012 Oct 20. Metab Brain Dis. 2013. PMID: 23086199 Review. - Hepatic encephalopathy: a dynamic or static condition.
Stewart CA, Cerhan J. Stewart CA, et al. Metab Brain Dis. 2005 Sep;20(3):193-204. doi: 10.1007/s11011-005-7207-x. Metab Brain Dis. 2005. PMID: 16167197 Review. - Multidimensional assessment of neuro-psychiatric symptoms in patients with low-grade hepatic encephalopathy: a clinical rating scale.
Mechtcheriakov S, Graziadei IW, Kugener A, Wiedemann J, Galbavy C, Hinterhuber H, Marksteiner J, Vogel W. Mechtcheriakov S, et al. World J Gastroenterol. 2005 Oct 7;11(37):5893-8. doi: 10.3748/wjg.v11.i37.5893. World J Gastroenterol. 2005. PMID: 16270405 Free PMC article. - MR imaging findings in hepatic encephalopathy.
Rovira A, Alonso J, Córdoba J. Rovira A, et al. AJNR Am J Neuroradiol. 2008 Oct;29(9):1612-21. doi: 10.3174/ajnr.A1139. Epub 2008 Jun 26. AJNR Am J Neuroradiol. 2008. PMID: 18583413 Free PMC article. Review. - X-ray fluorescence imaging of the hippocampal formation after manganese exposure.
Robison G, Zakharova T, Fu S, Jiang W, Fulper R, Barrea R, Zheng W, Pushkar Y. Robison G, et al. Metallomics. 2013 Nov;5(11):1554-65. doi: 10.1039/c3mt00133d. Metallomics. 2013. PMID: 23999853 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical